Mallory body induction in drug-primed mouse liver

Hepatology

Volumn 24, Issue 3, 1996, Pages 603-612

  Yuan, Qi X ^a   Marceau, Norman ^b   French, Barbara A ^a   Fu, Paul ^a   French, Samuel W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLATE DIETHYL ESTER; ALANINE AMINOTRANSFERASE; CYCLINE; CYTOKERATIN; DICARBOXYLIC ACID DERIVATIVE; GRISEOFULVIN; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIVER REGENERATION; MALE; MALLORY BODY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REFEEDING;

EID: 0029815047     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008781332     Document Type: Article

References (35)

1. Denk H, Eckertorfer R, Gschnait F, Konrad K, Wolff K. Experimental induction of hepatocellular hyalin (Mallory bodies) in mice by griseofulvin treatment. 1. Light microscopic studies. Lab Invest 1976;35:377-382.
2. Kimoff RJ, Huang S. Immunocytochemical and immunoelectron microscopic studies on Mallory bodies. Lab Invest 1981;45:491-503.
3. Denk H, Franke WW, Dragosics B, Zeiler I. Pathology of cytoskeletal of liver cells: demonstration of Mallory bodies (alcoholic hyaline) in murine and human hepatocytes by immunofluorescence microscopy using antibodies to cytokeratin polyptides from hepatocytes. HEPATOLOGY 1981;1:9-20.
4. Denk H, Zatloukal K, Preisegger K-H. The cytoskeleton-function and pathology: studies on the pathology of the intermediate filament cytoskeleton of the liver cell. Verh Dtsch Ges Pathol 1990;74:335-349.
5. Hutter H, Zatloukal K, Winter G, Stumptner C, Denk H. Disturbance of keratin homeostasis in griseofulvin-intoxicated mouse liver. Lab Invest 1993;69:576-582.
6. Preisegger K-H, Zatloukal K, Spurej G, Riegelnegg D, Denk H. Common epitopes of human and immune Mallory bodies and Lewy bodies as revealed by a neurofilament antibody. Lab Invest 1992;66:193-199.
7. Harst EW, Paget GE. Protoporphyrin, cirrhosis and hepatomata in the livers of mice given griseofulvin. Br J Dermatol 1963;75:105-112.
8. Tazawa J, Irie T, French SW. Mallory body formation runs parallel to 1-glutamyl transferase induction in hepatocytes of griseofulvin-fed mice. HEPATOLOGY 1983;3:989-1001.
9. Yokoo H, Harwood T, Racker D, Arak S. Experimental production of Mallory bodies in mice by diet containing 3,5-diethoxycarbonyl-1,4-dehydrocollidine. Gastroenterology 1982;83:109-113.
10. Yuan QX, Marceau N, French SW. Heat shock in vivo induces Mallory bodies in griseofulvin primed mouse liver. FASEB J 1995;9:A425.
11. Ohta M, Marceau N, Perry G, Manetto V, Gambetti P, Autilio-Gambetti L, et al. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Lab Invest 1988;59:848-856.
12. Chanda S, Mehendale HM. Role of nutritional fatty acid and L-carnitine in the final outcome of thioacetamide hepatoxicity. FASEB J 1994;8:1061-1068.
13. Kemler R, Brulet P, Schnebelen M-T, Gaillard J, Jacob F. Reactivity of monoclonal antibodies against intermediate filament proteins during embryonic development. J Embryol Exp Morphol 1981;64:45-60.
14. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
15. Bradford M. A rapid and sensitive method for the quantitation of micrograms quantities of proteins utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-256.
16. Zatloukal K, Spurej G, Rainer I, Lackinger E, Denk H. Fate of Mallory body-containing hepatocytes: disappearance of Mallory bodies and restoration of the hepatocytic intermediate filament cytoskeleton after drug withdrawal in the griseofulvin-treated mouse. HEPATOLOGY 1990;11:652-661.
17. French SW, Davies PL. The Mallory body in the pathogenesis of alcoholic liver disease. In: Khanna JM, Israel Y, Kalant H, editors. Alcoholic liver pathology. Toronto: Addiction Research Foundation of Ontario, 1975:113-143.
18. Denk H, Franke WW, Kerjaschki D, Eckerstorfer R. Mallory bodies in experimental animals and man. Int Rev Exp Pathol 1979;20:77-121.
19. Zatloukal K, Sohar R, Lackinger E, Denk H. Induction of heat shock proteins in short-term cultured hepatocytes derived from normal and chronically griseofulvin-treated mice. HEPATOLOGY 1988;8:607-612.
20. Yuan QX, French SW. Heat shock in vivo induces zone 3 necrosis in mice livers bearing drug induced Mallory bodies. HEPATOLOGY 1994;20:177A.
21. Salmhofer H, Rainer I, Zatloukal K, Denk H. Posttranslational events involved in griseofulvin-induced keratin cytoskeleton alterations. HEPATOLOGY 1994;20:731-740.
22. Preisegger K-H, Zatloukal K, Spurej G, Denk H. Changes of cytokeratin filament organization in human and murine Mallory body-containing livers as revealed by a panel of monoclonal antibodies. Liver 1991;11:300-309.
23. Cadrin M, French SW, Wong PTT. Alteration in molecular structure of cytoskeleton proteins in griseofulvin treated mouse liver: a pressure tuning infrared spectroscopy study. Exp Mol Pathol 1991;55:170-179.
24. Kachi K, Wong PTT, French SW. Molecular structural changes in Mallory body proteins in human and mouse livers: an infrared spectroscopy study. Exp Mol Pathol 1993;59:187-210.
25. Irie T, Benson NC, French SW. Electron microscopic study of the in vitro calcium-dependent degradation of Mallory bodies and intermediate filaments in hepatocytes. Lab Invest 1984;50:303-312.
26. Katsuma Y, Swierenga SHH, Khettry V, Marceau N, French SW. Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver. HEPATOLOGY 1987;7:1215-1223.
27. Kachi K, Cadrin M, French SW. Synthesis of Mallory body, intermediate filament, and microfilament proteins in liver cell primary cultures. Lab Invest 1993;68:71-81.
28. Cadrin M, Anderson NM, Aasheim LH, Kawahara H, Franks DJ, French SW. Modifications in cytokeratins and actin in cultured liver cells derived from griseofulvin-fed livers. Lab Invest 1995;72:453-460.
29. Rechsteiner M. Natural substrates of the ubiquitin proteolytic pathway. Cell 1991;66:615-618.
30. Ciechanover A, Schwartz AL. The ubiquitin-mediated proteolytic pathway: mechanisms of recognition of the proteolytic substrate and involvement in the degradation of native cellular proteins. FASEB J 1994;8:182-191.
31. Cadrin M, McFarlane-Anderson N, Aasheim LH, Kawahara H, Franks DJ, Marceau N, et al. Differential phosphorylation of CK8 and CK18 by 12-0-tetradecanoyl-phorbol-13-acetate in primary cultures of mouse hepatocytes. Cell Signal 1992;4:715-722.
32. Kawahara H, Cadrin M, French SW. Ethanol-induced phosphorylation of cytokeratin in cultured hepatocytes. Life Sci 1990;47:859-863.
33. Goldberg AL. Functions of proteosome: the lysis at the end of the tunnel. Science 1995;268:522-523.
34. Taubes G. Misfolding the way to disease. Science 1996;271:1493-1495.
35. Cadrin M, Marceau N, French SW. Cytokeratin of apparent high molecular weight in livers from griseofulvin-fed mice. J Hepatol 1992;14:226-231.